Kestra Medical Technologies, Ltd.
KMTS
$26.07
-$0.33-1.25%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -25.83M | -52.05M | -21.51M | -19.88M | |
| Total Depreciation and Amortization | 2.03M | 1.84M | 1.89M | 2.38M | |
| Total Amortization of Deferred Charges | 469.00K | 369.00K | 170.00K | 200.00K | |
| Total Other Non-Cash Items | 3.04M | 29.61M | 944.00K | 1.25M | |
| Change in Net Operating Assets | -5.98M | -3.46M | 123.00K | -1.44M | |
| Cash from Operations | -26.27M | -23.70M | -18.38M | -17.50M | |
| Capital Expenditure | -8.27M | -8.04M | -4.06M | -7.06M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 37.00K | 283.00K | -- | 23.00K | |
| Cash from Investing | -8.23M | -7.76M | -4.06M | -7.03M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 218.16M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 103.40M | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -1.88M | -3.46M | -119.00K | 12.85M | |
| Cash from Financing | -1.88M | 214.70M | -119.00K | 116.25M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -36.38M | 183.24M | -22.57M | 91.72M | |